PTC Therapeutics, Inc.
DHODH INHIBITOR FOR USE IN TREATING HEMATOLOGIC CANCERS

Abstract:

A method of use for Cpd 1 as an inhibitor of dihydroorotate dehydrogenase (DHODH) function in treating or ameliorating a hematological cancer in a subject in need thereof comprising, administering an effective amount of Cpd 1 to the subject, having structure (I); or a form or pharmaceutical composition thereof. ##STR00001##